Global burden of alcoholic liver diseases - PubMed (original) (raw)
Review
doi: 10.1016/j.jhep.2013.03.007. Epub 2013 Mar 16.
Affiliations
- PMID: 23511777
- DOI: 10.1016/j.jhep.2013.03.007
Free article
Review
Global burden of alcoholic liver diseases
Jürgen Rehm et al. J Hepatol. 2013 Jul.
Free article
Abstract
Liver diseases contribute markedly to the global burden of mortality and disease. This paper provides an overview from a global perspective of the contribution of alcohol to liver diseases. The Global Burden of Disease study methodology was used to estimate the burden of alcohol-attributable liver cirrhosis and alcohol-attributable liver cancer in 2010 as measured by deaths and disability adjusted life years (DALYs). This methodology estimates attributable fractions based on alcohol exposure distribution and relative risks associated with different levels of drinking. Globally, in 2010, alcohol-attributable liver cirrhosis was responsible for 493,300 deaths (156,900 female deaths and 336,400 male deaths) and 14,544,000 DALYs (4,112,000 DALYs for women and 10,432,000 DALYs for men), representing 0.9% (0.7% for women and 1.2% for men) of all global deaths and 0.6% (0.4% for women and 0.8% for men) of all global DALYs, and 47.9% of all liver cirrhosis deaths (46.5% for women and 48.5% for men) and 46.9% of all liver cirrhosis DALYs (44.5% for women and 47.9% for men). Alcohol-attributable liver cancer was responsible for 80,600 deaths (14,800 female deaths and 65,900 male deaths) and 2,142,000 DALYs (335,000 DALYs for women and 1,807,000 DALYs for men). The burden of alcohol-attributable liver cirrhosis and liver cancer is high and entirely preventable. Interventions to reduce alcohol consumption are recommended as a population health priority and may range from taxation increases for alcoholic beverages to increases in screening and treatment rates for alcohol use disorders.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
- Is heavy alcohol consumption an attributable risk factor for cancer-related deaths among Japanese men?
Makimoto K, Oda H, Higuchi S. Makimoto K, et al. Alcohol Clin Exp Res. 2000 Mar;24(3):382-5. Alcohol Clin Exp Res. 2000. PMID: 10776681 - Alcohol-attributable mortality in Switzerland in 2011--age-specific causes of death and impact of heavy versus non-heavy drinking.
Marmet S, Rehm J, Gmel G, Frick H, Gmel G. Marmet S, et al. Swiss Med Wkly. 2014 May 20;144:w13947. doi: 10.4414/smw.2014.13947. eCollection 2014. Swiss Med Wkly. 2014. PMID: 24845076 - Estimating the burden of disease attributable to alcohol use in South Africa in 2000.
Schneider M, Norman R, Parry C, Bradshaw D, Plüddemann A; South African Comparative Risk Assessment Collaborating Group. Schneider M, et al. S Afr Med J. 2007 Aug;97(8 Pt 2):664-72. S Afr Med J. 2007. PMID: 17952223 - Alcohol and mortality: Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010.
Rehm J, Shield KD. Rehm J, et al. Alcohol Res. 2013;35(2):174-83. Alcohol Res. 2013. PMID: 24881325 Free PMC article. Review. - Alcohol and smoking.
Singer MV, Feick P, Gerloff A. Singer MV, et al. Dig Dis. 2011;29(2):177-83. doi: 10.1159/000323882. Epub 2011 Jul 5. Dig Dis. 2011. PMID: 21734382 Review.
Cited by
- Peroxisome proliferator-activated receptor agonists: A new hope towards the management of alcoholic liver disease.
Durairajan SSK, Singh AK, Iyaswamy A. Durairajan SSK, et al. World J Gastroenterol. 2024 Sep 21;30(35):3965-3971. doi: 10.3748/wjg.v30.i35.3965. World J Gastroenterol. 2024. PMID: 39351059 Free PMC article. - Trends in the burden of hospitalised patients with cirrhosis in Switzerland: a cross-sectional study of cirrhosis-related hospitalisations between 1998 and 2020.
Favre-Bulle T, Moradpour D, Marques-Vidal P, Vaucher J. Favre-Bulle T, et al. BMJ Open. 2024 Aug 24;14(8):e081822. doi: 10.1136/bmjopen-2023-081822. BMJ Open. 2024. PMID: 39181561 Free PMC article. - Impacts of smoking on alcoholic liver disease: a nationwide cohort study.
Yoo JJ, Lee DH, Kim SG, Jang JY, Kim YS, Kim LY. Yoo JJ, et al. Front Public Health. 2024 Aug 7;12:1427131. doi: 10.3389/fpubh.2024.1427131. eCollection 2024. Front Public Health. 2024. PMID: 39171308 Free PMC article. - The LIVER CARE trial - screening for liver disease in individuals attending treatment for alcohol use disorder: a randomized controlled feasibility trial.
Jepsen P, von Wowern N, Madsen LG, Klausen MK, Düring S, Benthien KS, Winther-Jensen M, Petersen J, Askgaard G. Jepsen P, et al. Pilot Feasibility Stud. 2024 May 16;10(1):78. doi: 10.1186/s40814-024-01504-5. Pilot Feasibility Stud. 2024. PMID: 38755732 Free PMC article. - Sex-Specific Effect of Ethanol on Colon Content Lipidome in a Mice Model Using Nontargeted LC/MS.
Jayaprakash J, B Gowda SG, K Shukla P, Gowda D, Nath LR, Chiba H, Rao R, Hui SP. Jayaprakash J, et al. ACS Omega. 2024 Mar 29;9(14):16044-16054. doi: 10.1021/acsomega.3c09597. eCollection 2024 Apr 9. ACS Omega. 2024. PMID: 38617688 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources